Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 219313, 10 pages
http://dx.doi.org/10.1155/2013/219313
Research Article

Antiangiogenic VEGF Isoform in Inflammatory Myopathies

1Department of Medicine, Surgery and Neuroscience, University of Siena, Via A. Moro 2, 53100 Siena, Italy
2Department of Molecular and Developmental Medicine, University of Siena, Via A. Moro 2, 53100 Siena, Italy
3Child Neuropsychiatry Unit, University Hospital AOUS, Viale M. Bracci 16, 53100 Siena, Italy
4Department of Life Sciences and Biotechnologies, University of Ferrara, Via L. Borsari 46, 44121 Ferrara, Italy
5Department of Food and Nutrition, Kyung Hee University, Seoul 130-701, Republic of Korea

Received 12 March 2013; Revised 1 May 2013; Accepted 15 May 2013

Academic Editor: Jeffrey H. Ruth

Copyright © 2013 Nila Volpi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Control case: VEGFA expressed by muscle fibres IBM (adjacent section of Fig 3 1a-e) negative control by omission of primary antibodies. No stain is present on fibres, vessels, and connective tissue.

  1. Supplementary Material